由于下动脉伪动脉瘤引起的自发性大规模血胸病:内血管治疗方法
Resham Singh1, Annoushka Daniel1, Naveen Kumar1
1Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India.
Jornal vascular brasileiro
|January 23, 2026
概括
下动脉 (IPA) 伪动脉瘤很少见,但可能导致严重出血. 这一案例突显了急性呼吸不良和血胸病患者的成功内血管栓塞,导致完全康复.
科学领域:
- 血管外科 血管外科
- 干预性放射学 干预性放射学
- 胸部医学 胸部医学
背景情况:
- 下动脉 (IPA) 伪动脉瘤是一种罕见的血管病变.
- 破裂可能导致危及生命的血胸.
- 由于深部位置和非特异性症状,诊断具有挑战性.
研究的目的:
- 报告一个年轻女子患有下动脉伪动脉瘤的病例.
- 描述成功的内血管治疗这种情况.
- 强调成像在诊断非典型血胸病中的作用.
主要方法:
- 计算机断层扫描血管造影用于诊断.
- 使用粘合剂进行内血管栓塞:利皮多尔混合物.
- 血液胸部疏散. 血液胸部疏散.
主要成果:
- 成功地使左侧的 IPA 伪动脉瘤栓塞.
- 大规模左侧血胸的分辨率.
- 在2个月的随访期间,患者仍然无症状.
结论:
- 内血管栓塞是一种对IPA伪动脉瘤的微创和有效治疗方法.
- 截面成像对于早期诊断非典型血胸病至关重要.
- 及时治疗导致快速康复和最小的发病率.
相关概念视频
Spontaneity
28.9K
A spontaneous process is one that occurs naturally under certain conditions. A nonspontaneous process, on the other hand, will not take place unless it is “driven” by the continual input of energy from an external source. Processes have a natural tendency to occur in one direction under a given set of conditions. Water will naturally flow downhill (spontaneous process), but uphill flow (nonspontaneous process) requires outside intervention such as the use of a pump. Iron exposed to...
28.9K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
580
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
580
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
449
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
449
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
475
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
475
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
599
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
599
Spontaneous and Induced Mutations
2.1K
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
2.1K


